Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanyi Xiao

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Scientific Reports|February 12, 2025
Unveiling a novel model of cell senescence-related genes for prognostic assessment and immunotherapeutic insights in gastric cancerGang Wang, Yi Wang, Yanyi Xiao, et al.
Scientific Reports|August 30, 2024
Lymphocyte antigen 6 family member E suppresses apoptosis and promotes pancreatic cancer growth and migration via Wnt/β-catenin pathway activationKenan Cen, Jingyao Zhou, Xuejia Yang, et al.
Scientific Reports|February 24, 2025
Machine learning selection of basement membrane-associated genes and development of a predictive model for kidney fibrosisZiwei Yuan, Guangjia Lv, Xinyan Liu, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 17, 2023
Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathwayMiaomiao Lin, Yanyi Xiao, Yile Dai, et al.
Peerj|September 22, 2022
Sophocarpine inhibits tumor progression by antagonizing the PI3K/AKT/mTOR signaling pathway in castration-resistant prostate cancerMin Weng, Chenghao Shi, Hui Han, et al.
Aging|November 25, 2021
Fisetin inhibits the proliferation, migration and invasion of pancreatic cancer by targeting PI3K/AKT/mTOR signalingYanyi Xiao, Yilong Liu, Zhiwei Gao, et al.
Molecular Medicine (Cambridge, Mass.)|September 28, 2024
Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancerZhixuan Wu, Haoyi Xiang, Xiaowu Wang, et al.
Biochemical Pharmacology|November 22, 2020
Inhibition of proliferation-linked signaling cascades with atractylenolide I reduces myofibroblastic phenotype and renal fibrosisYangyang Guo, Yanyi Xiao, Hengyue Zhu, et al.
Aging|December 4, 2021
The isoflavone puerarin exerts anti-tumor activity in pancreatic ductal adenocarcinoma by suppressing mTOR-mediated glucose metabolismHengyue Zhu, Yanyi Xiao, Hangcheng Guo, et al.
Frontiers in Immunology|January 1, 2025
Identification and validation of the nicotine metabolism-related signature of bladder cancer by bioinformatics and machine learningYating Zhan, Min Weng, Yangyang Guo, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Scientific Reports|February 12, 2025
Unveiling a novel model of cell senescence-related genes for prognostic assessment and immunotherapeutic insights in gastric cancerGang Wang, Yi Wang, Yanyi Xiao, et al.
Scientific Reports|August 30, 2024
Lymphocyte antigen 6 family member E suppresses apoptosis and promotes pancreatic cancer growth and migration via Wnt/β-catenin pathway activationKenan Cen, Jingyao Zhou, Xuejia Yang, et al.
Scientific Reports|February 24, 2025
Machine learning selection of basement membrane-associated genes and development of a predictive model for kidney fibrosisZiwei Yuan, Guangjia Lv, Xinyan Liu, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 17, 2023
Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathwayMiaomiao Lin, Yanyi Xiao, Yile Dai, et al.
Peerj|September 22, 2022
Sophocarpine inhibits tumor progression by antagonizing the PI3K/AKT/mTOR signaling pathway in castration-resistant prostate cancerMin Weng, Chenghao Shi, Hui Han, et al.
Aging|November 25, 2021
Fisetin inhibits the proliferation, migration and invasion of pancreatic cancer by targeting PI3K/AKT/mTOR signalingYanyi Xiao, Yilong Liu, Zhiwei Gao, et al.
Molecular Medicine (Cambridge, Mass.)|September 28, 2024
Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancerZhixuan Wu, Haoyi Xiang, Xiaowu Wang, et al.
Biochemical Pharmacology|November 22, 2020
Inhibition of proliferation-linked signaling cascades with atractylenolide I reduces myofibroblastic phenotype and renal fibrosisYangyang Guo, Yanyi Xiao, Hengyue Zhu, et al.
Aging|December 4, 2021
The isoflavone puerarin exerts anti-tumor activity in pancreatic ductal adenocarcinoma by suppressing mTOR-mediated glucose metabolismHengyue Zhu, Yanyi Xiao, Hangcheng Guo, et al.
Frontiers in Immunology|January 1, 2025
Identification and validation of the nicotine metabolism-related signature of bladder cancer by bioinformatics and machine learningYating Zhan, Min Weng, Yangyang Guo, et al.
Pageof 2